Verigene Gram-Positive Blood Culture (Gc-Gp) Nucleic Acid Test
510(k) K122514
Active
Valid until
No expiry
FDA recalls
3 ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK122514 | Date19 Sep 2012 | StatusActive |
Recalls
-
- Ongoing Z-2533-2024
Potential for defective test cartridges which may result in false positive results for the Staphylococcus lugdunensis and Enterococcus faecium targets.
-
- Ongoing Z-0500-2024
Potentially defective utility trays in the reagent kits.
-
- Ongoing Z-2007-2021
Potential for a false-negative result.
-
- Terminated Z-2775-2020
An instrument failure mode that may result in a Blood Culture Gram Positive (BC-GP) or Gram Negative (BC-GN) false negative call.
-
- Terminated Z-0822-2019
On lot of VERIGENE(R) BC-GP Utility Kits (20-011-018) were labeled with the VERIGENE(R) Amplification Tray label.
-
- Terminated Z-0445-2019
Potential to lead to a false negative results.
-
- Terminated Z-2683-2014
Nanosphere has received several reports relating to an increased rate of Processing Errors during procedures performed on the Processor SP caused by Tips in Tip Holder Assemblies for the following products and lots of Extraction Trays.
-
- Terminated Z-2735-2014
There is a specific Extraction Tray lot containing Tips that may slightly increase the occurrence of Process SP Processing Error when used due to the Processor SP experiencing difficulty releasing the Tip to the final location in the Tip Assembly. The difficult releasing the Tip can result in a Processing Error and occasionally the Tip to be dropped into the Processor SP.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- PAM
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.3365
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent